| Item Type | Name |
|
Concept
|
Chest Pain
|
|
Concept
|
Pain
|
|
Concept
|
Pain Measurement
|
|
Concept
|
Pain, Intractable
|
|
Concept
|
Pain, Postoperative
|
|
Concept
|
Pain Threshold
|
|
Concept
|
Pelvic Pain
|
|
Concept
|
Pain Clinics
|
|
Concept
|
Neck Pain
|
|
Concept
|
Pain Management
|
|
Concept
|
Acute Pain
|
|
Academic Article
|
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
|
|
Academic Article
|
Migraine in women with chronic pelvic pain with and without endometriosis.
|
|
Academic Article
|
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
|
|
Academic Article
|
Drug overuse and rebound headache.
|
|
Academic Article
|
Olanzapine in the treatment of refractory migraine and chronic daily headache.
|
|
Academic Article
|
Intravenous propofol in the treatment of refractory headache.
|
|
Academic Article
|
Re: chronic daily headache in children and adolescents presenting to tertiary headache clinics.
|
|
Academic Article
|
Botulinum toxin type A: myths, facts, and current research.
|
|
Academic Article
|
Neurotoxins in the neurobiology of pain.
|
|
Academic Article
|
Anticonvulsants in migraine.
|
|
Academic Article
|
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.
|
|
Academic Article
|
Cardiovascular tolerability and safety of triptans: a review of clinical data.
|
|
Academic Article
|
Headache management for the pain specialist.
|
|
Academic Article
|
Can allodynic migraine patients be identified interictally using a questionnaire?
|
|
Academic Article
|
Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
|
|
Academic Article
|
Headaches in pregnancy.
|
|
Academic Article
|
The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE).
|
|
Academic Article
|
Botulinum neurotoxins: origins and basic mechanisms of action.
|
|
Academic Article
|
Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
|
|
Academic Article
|
Cephalalgiaphobia: a possible specific phobia of illness.
|
|
Academic Article
|
Combination therapy in acute migraine treatment: the rationale behind the current treatment options.
|
|
Academic Article
|
Cutaneous allodynia in the migraine population.
|
|
Academic Article
|
Multiple intracerebral hemorrhages after cervical epidural injections.
|
|
Academic Article
|
Migraine prophylaxis with botulinum toxin A is associated with perception of headache.
|
|
Academic Article
|
Headache prophylaxis with BoNTA: patient characteristics.
|
|
Academic Article
|
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
|
|
Academic Article
|
Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
|
|
Academic Article
|
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study.
|
|
Academic Article
|
Is the migraine brain super-active?
|
|
Academic Article
|
Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
|
|
Academic Article
|
Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.
|
|
Academic Article
|
Long-Term Pain Reduction Does Not Imply Improved Functional Outcome in Patients Treated With Combined Supraorbital and Occipital Nerve Stimulation for Chronic Migraine.
|
|
Academic Article
|
Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
|
|
Academic Article
|
Ketamine for Refractory Headache: A Retrospective Analysis.
|
|
Academic Article
|
Erenumab in the treatment of migraine.
|
|
Academic Article
|
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
|
|
Academic Article
|
Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
|
|
Academic Article
|
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.
|
|
Academic Article
|
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24?weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
|
|
Academic Article
|
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine.
|
|
Academic Article
|
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.
|
|
Academic Article
|
Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis.
|
|
Academic Article
|
Lidocaine infusions for refractory chronic migraine: a retrospective analysis.
|